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Abstract
Introduction: In well-developed countries scant attention is currently devoted to the risk of
unknown exposure to aflatoxins, highly toxic and carcinogenic compounds. Nevertheless,
unexpected ingestion of foods contaminated by these toxins can occasionally occur virtually
worldwide.
Case presentation: A 38-year-old woman living in Northern Italy developed unexplained
abdominal symptoms after ingestion of aflatoxin-contaminated meat. The possible relation between
symptoms and aflatoxins ingestion, the potential risk of hepatocellular carcinoma and the medical
management of the case are discussed.
Conclusion: In well-developed countries aflatoxins exposure should be considered in case of
unexplained abdominal symptoms. Cancer risk cannot be assessed, nevertheless individual counselling
and periodical medical examinations are recommended.
Introduction
Aflatoxins (AFs) are a group of difuranocoumarin deriva-
tives produced by certain strains of Aspergillus flavus and
parasiticus. Thereare4 primaryAFs,butaflatoxinB1(AFB1),
the most toxic, is usually predominant in foods [1].
Aspergilli are common in nature, and can colonize and
contaminate various foods and feeds under favourable
conditions of temperature and humidity [1].
AFs can also be found in the milk, liver and meat of
animals which are fed with contaminated feed [2-4].
Additionally, AFs are quite stable during cooking [2,4], so
decomposition is unlikely and absorption occurs also after
consumption of cooked food.
Both in humans and animals exposure is related to
consumption of contaminated food. Even if food con-
tamination is more frequent in tropical countries, AFs can
be found in a wide range of foods consumed in all world
areas [5,6].
AFs are highly toxic in both animals and humans [1,5],
and are included in Group 1 (“carcinogens for humans”)
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(IARC), being considered among the most potent liver
carcinogens. Nevertheless, cases of aflatoxicosis in humans
have rarely been reported, especially in well developed
countries. However the possibility of a large under-
diagnosis is generally acknowledged, especially if few
subjects are affected. A likely explanation is that medical
services are less developed in those countries where high
levels of AFs contamination in food occur while in well
developed areas exposure is unexpected, and therefore
cases may go unnoticed. The latter possibility is illustrated
in the case report hereby presented.
Case presentation
The subject is a 38-years-old woman living in Northern
Italy. She smokes about 20 cigarettes per day and usually
drinks 1-2 glasses of wine per day during meals. Her
dietary habits are peculiar: since long time she has been
having a marked preference for beef meat, while she does
not like other types of meat or fish, nor vegetables or fruit.
Accordingly her diet is substantially unbalanced, consist-
ing mainly in grilled or roasted beef meat. As her family
has long since had a cattle breeding, she is used to eating
almost exclusively meat from the family farm.
In the winter of 2004 the family farm animals started to
show various disorders, such as slowing growth rate,
delayed sexual development, gastrointestinal tract dis-
orders, increasing incidence of several infective diseases,
abortions and increase of overall mortality. The veteri-
narians considered different causes and carried over
various treatments, as antibiotic therapies, without sig-
nificant results. Aflatoxicosis is a rare disease in the area, as
a consequence the possibility of AFs intoxication was not
considered at the time.
For years the animal feed had been supplied by the same
producer, but in the late spring of 2007, among the
attempts applied to find a solution, the feed supplier was
changed.
In late summer of 2007 the cattle recovered and the
disorders gradually subsided. Later on (autumn 2007) the
patient’s family acknowledged that some analyses per-
formed on the animal feed back in 2006 had revealed
AFB1 levels up to 25 µg/kg. The maximum level of AFB1 in
animal feed permitted by the European Union (EU) is
5 µg/kg. Further data are missing, since the former supplier
refused to produce records about other analyses in feed.
Accordingly the possibility of higher concentrations of AFs
in feed exists. After the finding of high AFB1 levels in feed,
the symptoms and signs observed in the animals were
reconsidered by the farm veterinarians, who agreed that an
AFs intoxication was possible. Unfortunately it was not
possible to perform specific laboratory tests in the animals
since too much time had passed from the end of
contaminated feed consumption. However a relation
between the disorders observed in animals and AFs is
supported by documented feed AFB1 levels exceeding the
EU limit value, animal case history consistent with
aflatoxicosis, temporal correspondence between onset of
disorders and consumption of potentially contaminated
feed, and submission of disorders after feed replacement,
according to the temporality principle of causality.
In the subject under examination, previous medical
history did not account for any relevant disorder nor
hospitalization before winter of 2004, when episodes of
nausea, abdominal swelling, constipation alternating with
diarrhea and abdominal pain appeared. The frequency of
symptoms increased during the following months includ-
ing several episodes of intense abdominal pain.
The subject underwent several medical examinations to
rule out major causes of abdominal pain. Repeated
gastrointestinal X-rays and abdominal ultrasonography
were performed from May to September 2005, along with
a uterine ultrasound scan (November 2005), but they
showed no apparent alterations. In September 2005 a
stool examination was carried over and proved to be
negative for pathological microorganisms or parasites, and
no steatorrhea was observed. Antibody tests for celiac
disease were negative. Repeated blood analyses were
substantially normal, including pancreatic enzymes and
liver function tests (serum glutamic-pyruvic and glutamic-
oxaloacetic transaminases, alkaline phosphatase, gamma-
glutamyl transpeptidase, bilirubin, albumin and total
proteins). Blood viral hepatitis antibodies were negative.
During 2006-2007 abdominal pain was so intense that the
patient repeatedly attended the Emergency Department of
the local area hospital. Twice “mittelschmertz” was
diagnosed, other times a generic diagnosis of “acute
abdominal pain” was made. Tramadol was effective in
pain reduction.
During the whole period the subject’s diet remained
substantially unmodified, and she has never ceased eating
meet from the family farm. Nevertheless, after the animal
feed supplier was changed in autumn of 2007, the meat
was no more contaminated. The abdominal symptoms
subsided by October 2007, and no further episodes of
abdominal pain have ever since been reported.
The timing of signs and symptoms both in animals and in
the case are described in Table 1.
Discussion
The main target organ of AFs is the liver, and acute toxic
hepatitis with high mortality rates have been reported [7].
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[5], and gastrointestinal tract have been reported [8,9]. A
role of AFs in Reye syndrome and in kwashiorkor has been
assumed [1,10]. Other effects have been described, as an
interference with metabolic processes andvarious essential
micronutrients [1,5,10].
An assessment of the health risk possibly related to AFs
exposure is difficult as the toxicokinetics in humans is
complex and knowledge is incomplete [5]. In addition to
intensity and duration of exposure, several factors, such as
age and health conditions, seem to influence susceptibility
to AFs effects [5].
Diet supposedly plays an important role as well [11]. One
case of AFS acute intoxication in a well developed country
has been described: a female laboratory worker in USA
attempted suicide by repeatedly ingesting high doses of
purified AFs. Except for transient rash, nausea and
headache, she apparently had no adverse effects. Further-
more, in a 14-year follow-up she showed no signs of liver
cancer [12]. This might suggest that in well-nourished
persons AFB1 hepatotoxicity is lower than in experimen-
tal animals or in populations with poor nutrition, and
that the growth latency of AFs-induced tumour may
exceed 14 years.
Moreover, adverse effects related to AFs exposure can easily
remain unrecognized by medical professionals, especially
in well-developed countries. In fact diagnosis may be
difficult, and frequently the demonstration of the role of
AFs may be possibly based on likelihood criteria only, as
in the case presented here.
In our patient it was impossible to measure AFs or their
derivatives as exposure biomarkers [5] since the case came
to our attention several months after interruption of the
ingestion. Likewise, no reliable appraisal of the AFs
ingested dose is possible. Nevertheless, the unbalanced
diet, based on an excessive amount of beef meat, induced
an unusually high exposure to these toxins, possibly
furthering the onset of disorders.
The abdominal symptoms observed in our case are
included among symptoms usually reported in AFs
intoxication [9,10], and may be related to a direct effect
of AFs in the colon, as described both in vitro [9] and in
experimental animals [8]. The absence of other clinical
adverse effects is consistent with knowledge about AFs
exposure in well developed countries [12].
Causes of abdominal pain other than AFs were not
identified despite repeated medical examinations and
tests. No liver effects were observed performing blood
analyses and ultrasound scans, but scientific literature has
previously reported such findings in well nourished
subjects [12].
The association between the patient’s symptoms and AFs
ingestion is therefore supported by several facts: i) the
patient consumed meat from contaminated animals; ii)
the clinical history is consistent with AFs intoxication,
according to literature data; iii) atemporal correspondence
is observed between the onset of disorders and the
consumption of contaminated meat as well as between
the withdrawal of symptoms and the stop of consump-
tion; iv) no other causes were identified.
An open question is the risk of hepatocellular carcinoma
(HCC). The carcinogenic activity of AFB1 is possibly
related to its 8, 9-epoxide metabolite which can react with
DNA. It can induce mutations in the codon 249 of the p53
Table 1. Time-line of symptoms and signs in the animals and in the case
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The risk of HCC depends on different factors, among
which the most important is hepatitis virus chronic
infection. Two epidemiological studies accomplished in
China showed thattherelative risk of developing HCCwas
3.4 in AFs exposed in relation to unexposed, and about
59 in case of both AFs exposure and positive HBsAg status
[14]. The extrapolation of these data to EU population is
difficult, nevertheless scientific evidence suggests that all
doses may have a cumulative effect on the risk of
developing cancer [5].
As to our case, the cancer risk assessment is impossible due
to the lack of quantitative data about the ingested dose.
Molecular cytogenetic tests were not performed in the
patient. The diet of the patient was unbalanced, being
poor in fruit and vegetables, which are known to reduce
cancer risk [15].
As regards the medical management of the case, the use of
chemopreventive agents as oltipraz or chlorophyllin,
proposed in exposed subjects in endemic areas [15], is
not recommended. Rather a vaccination is advised, as the
subject is currently in a negative HBsAg status, and
hepatitis B virus increases the risk of HCC. Furthermore,
a periodical medical follow up is proposed. Restriction of
alcohol intake and a more balanced diet are also
recommended.
Conclusion
The case hereby presented emphasizes the possibility of
missing AFs exposure in well developed Countries, and
suggests the need to consider an unnoticed AFs exposure
in case of unexplained abdominal symptoms.
HCC risk related to AFs consumption cannot be usually
assessed, nevertheless individual counselling for exposed
people should take into account HBV vaccination, period-
ical medical examinations, alcohol restriction and a well-
balanced diet.
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